Key facts
- It has raised $79.0M; the latest was PE Growth/Expansion in Aug 2024.
- Notable investors include Google for Startups, Global Brain, Samsung NEXT Ventures, RiverPark Ventures, Pitango Venture Capital — 32 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Lumen
- ·The full record, as it builds
Funding rounds
No funding rounds for Lumen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lumen
Developer of a metabolism measurement device designed to provide daily personalized nutrition based on metabolic data. The company's device is a small portable breathalyzer that measures metabolism through the breath in real-time and changes the way people eat and manage their bodies to live a healthier life by dieting, enabling users to get a full understanding of whether they are on a trend to lose or gain weight and offers the knowledge about the tools to control weight.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2014
- Employees
- 171
- Website
- lumen.me/
- Ownership
- Privately Held (backing)
Lumen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lumen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lumen in its N-PORT filings yet. We sweep new filings monthly.